Hunan Er-Kang Pharmaceutical Co., Ltd (SHE:300267)
3.230
-0.050 (-1.52%)
Sep 10, 2026, 1:45 PM CST
SHE:300267 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 884.31 | 897.4 | 698.54 | 744.35 | 764.67 | 761.56 |
Trading Asset Securities | 20 | 90 | 120 | 0.12 | 114.12 | - |
Cash & Short-Term Investments | 904.31 | 987.4 | 818.54 | 744.47 | 878.79 | 761.56 |
Cash Growth | 35.47% | 20.63% | 9.95% | -15.28% | 15.39% | -40.90% |
Accounts Receivable | 216.55 | 202.39 | 198.3 | 177.8 | 204.48 | 274.36 |
Other Receivables | 2.39 | 3.62 | 4.46 | 18.17 | 27.81 | 13.57 |
Receivables | 218.94 | 206.02 | 202.77 | 195.97 | 232.29 | 287.93 |
Inventory | 750.16 | 512 | 600.78 | 691.6 | 821.34 | 714.77 |
Prepaid Expenses | - | - | - | 1.39 | - | - |
Other Current Assets | 100.11 | 83.15 | 95 | 97.58 | 158.78 | 182.1 |
Total Current Assets | 1,974 | 1,789 | 1,717 | 1,731 | 2,091 | 1,946 |
Property, Plant & Equipment | 2,340 | 2,425 | 2,716 | 2,917 | 2,857 | 2,604 |
Long-Term Investments | 99.59 | 99.8 | 121.74 | 170.23 | 188.97 | 196.16 |
Goodwill | 2 | 2 | 2 | 2 | 10.01 | 10.01 |
Other Intangible Assets | 307.84 | 317.12 | 363.56 | 378.03 | 406.14 | 431.45 |
Long-Term Deferred Tax Assets | 112.99 | 120.4 | 150.55 | 152.14 | 168.92 | 118.34 |
Long-Term Deferred Charges | 8.1 | 9.56 | 10.66 | 12.08 | 19.5 | 16.51 |
Other Long-Term Assets | 136.27 | 98.25 | 117.78 | 116.25 | 114.6 | 108.75 |
Total Assets | 4,980 | 4,861 | 5,200 | 5,479 | 5,856 | 5,432 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 142.95 | 121.07 | 114.66 | 122.3 | 198.7 | 137.87 |
Accrued Expenses | 14.91 | 33.02 | 26.09 | 31.22 | 23.38 | 33.79 |
Short-Term Debt | 689.33 | 551.38 | 488.2 | 341.89 | 396.64 | 246 |
Current Portion of Leases | - | 8.79 | 3.69 | 2.16 | 4.11 | 3.88 |
Current Income Taxes Payable | 5.18 | 0.02 | 0.17 | 0.99 | 0.97 | 0.74 |
Current Unearned Revenue | 30.83 | 26.17 | 29.82 | 47.01 | 51.31 | 37.35 |
Other Current Liabilities | 58.92 | 62.27 | 42.71 | 57.73 | 50.33 | 39.3 |
Total Current Liabilities | 950 | 802.73 | 705.34 | 603.3 | 725.43 | 498.93 |
Long-Term Leases | 23.63 | 27.86 | 17.38 | 1.17 | 2.58 | 2.15 |
Long-Term Unearned Revenue | 8.34 | 10.06 | 14.93 | 18.39 | 23.15 | 27.91 |
Long-Term Deferred Tax Liabilities | 44.72 | 46.32 | 46.9 | 46.2 | 53.41 | 29.29 |
Other Long-Term Liabilities | - | - | 12.99 | - | - | - |
Total Liabilities | 1,027 | 886.97 | 797.54 | 669.05 | 804.57 | 558.28 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 2,063 | 2,063 | 2,063 | 2,063 | 2,063 | 2,063 |
Additional Paid-In Capital | 1,019 | 1,019 | 1,019 | 1,019 | 1,005 | 998.96 |
Retained Earnings | 968.58 | 924.27 | 1,304 | 1,677 | 1,935 | 1,889 |
Comprehensive Income & Other | -28.22 | 27.95 | 61.27 | 76.52 | 48.34 | -99.15 |
Total Common Equity | 4,022 | 4,034 | 4,447 | 4,836 | 5,051 | 4,851 |
Minority Interest | -69.28 | -60.24 | -45.23 | -26.03 | 0.27 | 22.49 |
Shareholders' Equity | 3,953 | 3,974 | 4,402 | 4,810 | 5,051 | 4,874 |
Total Liabilities & Equity | 4,980 | 4,861 | 5,200 | 5,479 | 5,856 | 5,432 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 720.85 | 588.03 | 509.27 | 345.21 | 403.33 | 252.04 |
Net Cash (Debt) | 183.47 | 399.38 | 309.27 | 399.25 | 475.46 | 509.53 |
Net Cash Growth | -43.10% | 29.13% | -22.54% | -16.03% | -6.69% | -38.28% |
Net Cash Per Share | 0.09 | 0.19 | 0.15 | 0.19 | 0.23 | 0.25 |
Filing Date Shares Outstanding | 2,069 | 2,063 | 2,063 | 2,063 | 2,063 | 2,063 |
Total Common Shares Outstanding | 2,069 | 2,063 | 2,063 | 2,063 | 2,063 | 2,063 |
Working Capital | 1,024 | 985.84 | 1,012 | 1,128 | 1,366 | 1,447 |
Book Value Per Share | 1.94 | 1.96 | 2.16 | 2.34 | 2.45 | 2.35 |
Tangible Book Value | 3,713 | 3,715 | 4,082 | 4,456 | 4,635 | 4,410 |
Tangible Book Value Per Share | 1.79 | 1.80 | 1.98 | 2.16 | 2.25 | 2.14 |
Buildings | - | 1,897 | 1,933 | 1,990 | 1,926 | 1,740 |
Machinery | - | 1,734 | 1,914 | 1,878 | 1,896 | 1,224 |
Construction In Progress | - | 212.28 | 174.58 | 220.89 | 52.92 | 506.18 |